Safety and efficacy of intravenous tranexamic acid in endoscopic transurethral resections in urology: Prospective randomized trial;Intérêt de l'acide tranexamique dans les résections endoscopiques urologiques: étude prospective randomisée

Progres en Urologie

Volumn 27, Issue 16, 2017, Pages 1036-1042

  Jendoubi, A ^a   Malouch, A ^a   Bouzouita, A ^a   Riahi, Y ^a   Necib, H ^a   Ghedira, S ^a   Houissa, M ^a  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Bladder tumor; Hemorrhage; Tranexamic acid; Transurethral resection of prostate

Indexed keywords

ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID;

ADULT; AGED; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTECTOMY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; OPERATIVE BLOOD LOSS; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URETEROSCOPY; URETHRA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; CYSTECTOMY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANEXAMIC ACID; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME; URETEROSCOPY; URETHRA;

EID: 85032024573     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2017.09.008     Document Type: Article

References (21)

1. Rassweiler, J., Teber, D., Kuntz, R., Hofmann, R., Complications of trans urethral resection of the prostate (TURP) – incidence, management, and prevention. Eur Urol 50 (2006), 969–980.
2. Herr, H.W., Donat, M.S., Quality control in transurethral resection of bladder tumors. BJU Int 102 (2008), 1242–1246.
3. Collado, A., Cechile, G.E., Salvador, J., Vicente, J., Early complications of endoscopic treatment for superficial bladder tumors. J Urol 164 (2000), 1529–1532.
4. Nieder, A.M., Meinbach, D.S., Kim, S.S., Soloway, M.S., Transurethral bladder tumor resection: intraoperative and postoperative complications in a residency setting. J Urol 174 (2005), 2307–2309.
5. Pycha, A., Lodde, M., Lusuardi, L., et al. Teaching transurethral resection of the bladder: still a challenge?. Urology 62 (2003), 46–48.
6. Musallam, K.M., Tamim, H.M., Richards, T., Spahn, D.R., Rosendaal, F.R., Habbal, A., et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 378 (2011), 1396–1407.
7. Dunne, J.R., Malone, D., Tracy, J.K., Gannon, C., Napolitano, L.M., Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res 102 (2002), 237–244.
8. Tenborn, L., Blombäck, M., Berntorp, E., Tranexamic acid – an old drug still going strong and making a revival. Thromb Res 135:2 (2015), 231–242.
9. Crescenti, A., Borghi, G., Bignami, E., Bertarelli, G., Landoni, G., Casiraghi, G.M., et al. Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retro pubic prostatectomy: double blind, randomized, placebo controlled trial. BMJ, 343, 2011, d5701.
10. Rannikko, A., Petas, A., Taari, K., Tranexamic acid in control of primary hemorrhage during transurethral prostatectomy. Urology 64 (2004), 955–958.
11. Kumsar, S., Dirim, A., Toksöz, S., Sağlam, H.S., Adsan, O., Tranexamic acid decreases blood loss during transurethral resection of the prostate (TUR-P). Cent Eur J Urol 64 (2011), 156–158.
12. Zaid, H.B., Yang, D.Y., Tollefson, M.K., Frank, I., Winters, J.L., Thapa, P., et al. Efficacy and safety of intraoperative tranexamic acid infusion for reducing blood transfusion during radical cystectomy. Urology 92 (2016), 57–62.
13. www.has-sante.fr/portail/upload/docs/application/pdf/2015-02/transfusion de globules rouges homologues-produits-indications-alternatives-recommanadations.pdf.
14. Schultz, M., van der Lelie, H., Microscopic haematuria as a relative contraindication for tranexamic acid. Br J Haematol 89 (1995), 663–664.
15. Kumar, S., Randhawa, M.S., Ganesamoni, R., Singh, S.K., Tranexamic acid reduces blood loss during percutaneous nephrolithotomy: a prospective randomized controlled study. J Urol 189 (2013), 1757–1761.
16. Nielsen, J.D., Gram, J., Holm-Nielsen, A., et al. Post-operative blood loss after transurethral prostatectomy is dependent on in situ fibrinolysis. Br J Urol 80 (1997), 889–893.
17. Nielsen, J.D., Gram, J., Fabrin, K., Holm-Nielsen, A., Jespersen, J., Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate. Br J Urol 80 (1997), 105–110.
18. Babjuk, M., Transurethral resection of non-muscle-invasive bladder cancer. Eur Urol Supp 8 (2009), 542–548.
19. Henry, D.A., Carless, P.A., Moxey, A.J., O'Connell, D., Stokes, B.J., Fergusson, D.A., et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev, 3, 2011, CD001886.
20. Tan, J., Chen, H., Liu, Q., Chen, C., Huang, W., A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty. J Surg Res 184 (2013), 880–887.
21. Fagerström, T., Nyman, C.R., Hahn, R.G., Bipolar transurethral resection of the prostate causes less bleeding than the monopolar technique: a single-centre randomized trial of 202 patients. BJU International 105 (2010), 1560–1564.